Futurity

Share

Futurity

 •  September 13

A new drug is effective against non-severe cases of malaria, clearing the parasite responsible for the disease within a week, a new study reports. The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments. New...

Futurity

 •  August 7

Researchers have developed a new method for evaluating drug safety that can detect stress on cells at earlier stages than current methods, which mostly rely on detecting cell death. The new method uses a fluorescent sensor that is turned on in a cell when misfolded proteins begin to aggregate—an early sign of cellular stress. The method can be...

Futurity

 •  May 22

A small clinical trial suggests that some patients with severe asthma may benefit from treatment with a targeted cancer drug. The findings show that imatinib (brand name Gleevec), commonly prescribed to treat chronic myeloid leukemia, also targets specific immune cells known to drive inflammation in the lungs. “We are still in the early phase of...